Study of Ataluren (PTC124) in Hemophilia A and B

NCT00947193 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated early due to Sponsor decision and not reflective of adverse safety findings.

Conditions

Hemophilia A
Hemophilia B

Interventions

DRUG: Ataluren

Sponsor

PTC Therapeutics

Collaborators

[object Object]